Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia
Clinical trial NCT03796390 · UNKNOWN
Trial details
- NCT number
- NCT03796390
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-26
- Primary completion
- 2020-11-06
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.